Indeed, a role for the KDM5A histone demethylase in mediating drug tolerance in PC9 cells was observed in the Sharma et al. study [1], and similarly, KDM5B has been shown to mediate the development of BRAF inhibitor tolerance in melanoma [6]. Here, BRAF is linked to melanoma.